Effectiveness of oritavancin for management of skin and soft tissue infections in the emergency department: A case series

This publication has 14 references indexed in Scilit:

• Finding the niche: An interprofessional approach to defining oritavancin use criteria in the emergency department
  The American Journal of Emergency Medicine, 2020
• A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO Program
  Open Forum Infectious Diseases, 2018
• Single-Dose Oritavancin Compared to Standard of Care IV Antibiotics for Acute Bacterial Skin and Skin Structure Infection in the Outpatient Setting: A Retrospective Real-World Study
  Infectious Diseases and Therapy, 2017
• Increasing Incidence, Cost, and Seasonality in Patients Hospitalized for Cellulitis
  Open Forum Infectious Diseases, 2017
• Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
  Infectious Diseases and Therapy, 2016
• Economic Impact of Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in the Emergency Department or Observation Setting: Cost Savings Associated with Avoidable Hospitalizations
  Clinical Therapeutics, 2016
• Oritavancin: A Long-Half-Life Lipoglycopeptide
  Clinical Infectious Diseases, 2015
• Factors Associated with the Decision to Hospitalize Emergency Department Patients with a Skin and Soft Tissue Infection
  Western Journal of Emergency Medicine, 2015
• Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
  Clinical Infectious Diseases, 2014
• The "Epic" Challenge of Optimizing Antimicrobial Stewardship: The Role of Electronic Medical Records and Technology
  Clinical Infectious Diseases, 2013